A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus.

Fawsitt, Christopher G; Vickerman, Peter; Cooke, Graham; Welton, Nicky J; STOP-HCV Consortium; (2019) A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus. VALUE IN HEALTH, 22 (6). pp. 693-703. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2018.12.011

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jval.2018.12.011

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID 31198187
Elements ID 151211

Share

Download

Filename: 1-s2.0-S1098301519301019-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar